Business News | Takeda Accelerates Access to Its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E.
Get latest articles and stories on Business at LatestLY. Singapore, February 27: Takeda (TSE:4502/NYSE:TAK) today announced a strategic partnership with Biological E. Limited, a leading vaccines and biologics company in India, to manufacture Takeda's dengue vaccine, TAK-003. The partnership marks a crucial step in the fight against the global public health threat of dengue fever, aligning with the disease-specific target set by the World Health Organization (WHO) to achieve zero case-fatality rate due to dengue by 2030[i]. Business News | Takeda Accelerates Access to Its Dengue Vacci...
Source: latestly.com